|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
ù������ |
|
Ƥ���� |
| ��������������� | |
|
�º������� |
|
��־����У |
| PubMed | |
|
Article by �º������� |
|
Article by ��־����У |
ù��������Ƥ���������е�Ӧ��
�º�������1, ��־����У2
1. ������Ƥ����������;
2. �㶫ҽѧԺƤ���Բ��о���
ù��������һ�������������Ƽ�,����ѡ���Ե�����T��B�ܰ�ϸ���еĴλ����ʺ���������ø��������������ЧӦ,�ڷ���Ѹ��ˮ��Ϊù����,������Ӧ������������ù�������ѱ�����������м����Ѱ�������崯�������������崯���Ǵ�������������Ƥ����,��ȡ���˿�ϲ����Ч��
1. ������Ƥ����������;
2. �㶫ҽѧԺƤ���Բ��о���
1. ������Ƥ����������;
2. �㶫ҽѧԺƤ���Բ��о���
[2] Laliberte J, Yee A, Xiong Y, et al. Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood, 1998,91(8):2896-2904.
[3] Blaheta RA, Lockel K, Wittig B, et al. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil. Transpl Immunol, 1998,6(4):251-259.
[4] Penny MJ, Boyd RA, Hall BM. Mycophenolate mofetil prevents the induction of active Heymann nephritis:association with Th2 cytokine inhibiton. J Am Soc Nephrol, 1998,9(12):2272-2282.
[5] Hood KA, Zarembski DG. Mycophenolate mofetil:a unique immunosuppressive agent. Am J Health Syst Pharm, 1997,54(3):285-294.
[6] Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet, 1998,34(6):429-455.
[7] Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol, 1999, 135(1):54-56.
[8] Bredlich RO, Grundmann-Kollmann M, Behrens S, et al. Mycophenolate mofetil monotherapy for pemphigus vulgaris. Br J Dermatol, 1999,141(5):934.
[9] Grundmann-Kollmann M, Korting HC, Behrens S, et al. Mycophenolate mofetil:a new therapeutic option in the treatment of blistering autoimmune diseases. J Am Acad Dermatol, 1999,40(6 Pt 1):957-960.
[10] Nousari HC, Griffin WA, Anhalt GJ, et al. Successful therapy for bullous pemphigoid with mycophenolate mofetil. J Am Acad Dermatol, 1998,39(3):497-498.
[11] Nousari HC, Sragovich A, Kimyai-Asadi A, et al. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. JAm Acad Dermatol,1999,40(2 Pt 1):265-268.
[12] Haufs MG, Beissert S, Grabbe S, et al. Psoriasis vulgaris treated successfully with mycophenolate mofetil. Br J Dermatol, 1998,138(1):179-181.
[13] Geilen CC, Tebbe B, Garcia-Bartels C, et al. Successful treatment of erythrodermic psoriasis with mycophenolate mofetil. Br J Dermatol, 1998, 138(6):1101-1102.
[14] Glicklich D, Acharya A. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Am J Kidney Dis, 1998, 32(2):318-322.
[15] Dooley MA. Cosio FG, Nachman PH, et al. Mycophenolate mofetil therapy in lupus nephritis:clinical observations. J Am Soc Nephrol, 1999, 10(4):893-839.
[16] Gaubitz M, Schorat A, Schotte H, et al. Mycophenolate mofetil for the treatment of systemic lupus erythematosus:an open pilot trial. Lupus,1999,8(9):731-736.
[17] Grundmarn-Kollmann M, Korting HC, Behrens S, et al. Successfully treatment of severe refractory atopic dermatitis with mycophenolate mofetil. Br J Dermatol, 1999,141(1):175-176.
[18] Nousari HC, Goyal S, Anhalt GJ, et al. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil. Arch Dermatol, 1999,135(11):1420-1421.
[19] Gnmdmann-Kollmann M, Behrens S, Gruss C, et al. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVAl phototherapy. J Am Acad Dermatol, 2000,42(1 Pt 1):134-136.
[20] Nousari HC, Lynch W, Anhalt GJ, et al. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol, 1998,134(12):1509-1511.
[21] Enk AH, Knop J. Treatment of relapsing idiopathic nodular panniculitis(Pfeifer-Weber-Christian disease) with mycophenolate mofetil. J Am Acad Dermatol, 1998,39(3):508-509.
[22] Williams JV, Marks JG, Billingsley EM, et al. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol,2000,142(3):506-508.
[23] Schattenkirchner S, Eming S, Hunelmann N, et al. Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting. Br J Dermatol, 1999,141(5):932-933.